BDRX Biodexa Pharmaceuticals
- 1.3200
- -0.1900-12.58%
- 1.2700
- -0.0500-3.79%
Biodexa Pharmaceuticals News
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending modestly lower Wednesday morning, declining 0.36% to 1,359.56 on the S&P Europe Select ADR Index. From continental Euro
Biodexa's Licensor Emtora To Announce Phase 2 Clinical Trial Results Of ERapa In Familial Adenomatous Polyposis To Be Presented At Prestigious 2024 Digestive Disease Week Annual Meeting
Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual MeetingBiodexa Pharmac
Annovis Bio, Cyclacel Pharmaceuticals, Biodexa Pharmaceuticals Among Healthcare Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersDeciphera Pharmaceuticals (NASDAQ:DCPH) stock rose 71.0% to $25.05 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Koninklijke Philips (NYSE
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Shares of Koninklijke Philips N.V. (NYSE:PHG) rose sharply in today's pre-market trading after reporting first-quarter results. The company also resolved the respironics personal injury and medical mo
Dow Surges Over 200 Points; Microsoft Shares Gain Following Upbeat Earnings
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 200 points on Friday.The Dow traded up 0.57% to 38,303.11 while the NASDAQ rose 2.01% to 15,925.77. The
Trending Stocks Today: Biodexa Pharmaceuticals Surges 62.8%
April 26th - US stocks trending in regular trading hours.Gainers: $Biodexa Pharmaceuticals(BDRX.US)$ shoots up 62.8% to $1.18 with a turnover of $88.32 million. $Snap Inc(SNAP.US)$ soars 29.16% to $14
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Aon posted adjusted earnings of $5.66 per share, missing ma
Sector Update: Health Care Stocks Higher in Afternoon Trading
Health care stocks were rising Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.2%. The iShares Biotechnology ETF (IBB) rose 1%. In cor
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.5% to 1,380.32 on the S&P Europe Select ADR Index. With the gain, the index is set to c
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump
Biodexa Pharmaceuticals (BDRX) said Friday it has signed a deal with Emtora Biosciences for the exclusive, global rights for eRapa, a phase 3-ready drug to treat familial adenomatous polyposis, an inh
US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 Points
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining by more than 200 points on Friday.Following the market opening Friday, the Dow traded up 0.20% to 38,162.13 while the NASDAQ r
Express News | Biodexa Pharmaceuticals Shares Resume Trade
Express News | Biodexa Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 104.2%
Express News | Biodexa Shares Are Trading Higher After the Company Entered an Exclusive License Agreement With Rapamycin Holdings for the Rights to ERapa
Biodexa Enters Into Exclusive License To ERapa, A Phase 3 Ready Asset For The Treatment Of Familial Adenomatous Polyposis; Worldwide Rights Come With $17M In Non-Dilutive Grant Funding For Pivotal Phase 3 Trial In FAP
Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")Biodexa Enters Into Exclusive License to eRapa, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP)Worldwide rights co
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index
Analysis
Price Target
No Data
